KBKatharine BarMDSlidesetRSVCOVID-19COVID-19 Clinical Management Workshop 2021Monoclonal Antibodies for SARS-CoV-2 - Katharine Bar, MDView Slideset
RSRobert ShaferMDSlidesetRSVCOVID-19COVID-19 Clinical Management Workshop 2021SARS-CoV-2 Variants and Disease Severity - Robert Shafer, MDView Slideset
DKDaniel KuritzkesMDSlidesetRSVCOVID-19COVID-19 Clinical Management Workshop 2021COVID-19 Therapeutics: State-Of-The-Art - Daniel Kuritzkes, MDView Slideset
MVMarta VasylyevMDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022HIV Care and War in UkraineView Slideset
PGPierre-Marie GirardMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Implementing LA-ARVs in Europe: Which Patient? Which Formulation?View Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Implementing LA-ARVs in Europe: Which Patient? Which Formulation?View Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022HIV Transmission Clusters in Europe: A Perspective View of Late Presenters and Non-Late PresentersView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Transmitted Drug Resistance to Integrase Based First-Line Treatment in Europe, 2018-2021View Slideset
AMAnne-Geneviève MarcelinMDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022New Antiretroviral Compounds: What Are the Resistance Concerns?View Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022New Antiretroviral Compounds: What Are the Resistance Concerns?View Slideset
LVLinos VandekerckhoveMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022The Top 10 Important Observations Last YearView Slideset
EGEnrico GirardiMDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Country Experiences: Southern Europe / ItalyView Slideset
